Overview
This study will be a single-site, two-arm randomized controlled trial conducted among Spanish-speaking chronic pain patients. Chronic pain patients will be randomized by a computer-generated randomization schedule with simple random allocation (1:1) to either One MORE or a wait-list control condition (WLC). One MORE will be delivered individually either in-person or via a HIPAA compliant virtual meeting platform.
Eligibility
Inclusion Criteria:
- Spanish-speaking
- Age 18+
- Diagnosed with a chronic pain condition
- Average pain in the previous week > or = 3
- Willingness to participate in study interventions and assessments.
Exclusion Criteria:
- Non Spanish-speaking
- Score of 10 or greater ('high risk') on the suicidality subsection of the MINI
- Psychotic episode within the last 12 months as deemed by the corresponding subsection of the MINI
- Presence of clinically unstable illness judged to interfere with treatment or study procedures
- Unable or unlikely to complete study procedures (e.g., planned major surgery, anticipated move, travel barrier)
- Communication or cognitive impairment that limits participation in treatment or study procedures.